KIT and intrahepatic cholangiocarcinoma: The alteration of ICC number and function has been found to be related with the disrupted GI motility of various diseases including IBD.[16] ICCs express the receptor tyrosine kinase c‐Kit and depend on c‐Kit‐stem cell factor signaling for their development.